Skip to main content

Table 1 The clinicopathologic factors associated with recurrence/progression in MOGCTs

From: Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution

Variables No. Patients (%) Recurrence No
(Rate, %)
P value
Age, years    
   < 20 26(45.6) 2(3.5) 0.1177
   20-40 28(49.1) 3(5.3)  
   > 40 3(5.3) 1(1.8)  
Histological diagnosis    
   Dysgerminoma 20(35.1) 0(0.0) < 0.0001
   Immature teratoma 24(42.1) 1(1.8)  
   Endodermal sinus tumor 8(14.0) 2(3.5)  
   Choriocarcinoma 4(7.0) 2(3.5)  
   Mixed germ cell tumor 1(1.8) 1(1.8)  
Histological diagnosisa    
   Dysgerminoma 20(35.1) 0(0.00) 0.0716
   Non-dysgerminoma 37(64.9) 6(10.5)  
Stage    
   I 38(66.7) 1(1.8) 0.0052b
   II 3(5.2) 0(0.0)  
   III 15(26.3) 4(7.0)  
   IV 1(1.8) 1(1.8)  
Volume of ascites, cc    
   < 100 33(57.9) 2(3.5) 0.1277
   ≥ 100 24(42.1) 4(7.0)  
Elevated AFP, ng/ml (n = 46)    
   < 100 36(78.3) 4(8.7) 0.4089
   ≥ 100 10(21.7) 2(4.4)  
Beta-hCG (n = 53)    
   Normal 45(84.9) 3(5.7) 0.0134
   Elevated 8(15.1) 3(5.7)  
  1. AFP, alpha-fetoprotein; hCG, human gonadotrophic hormone.
  2. a Comparison between two groups.
  3. b Comparison between stage I-II and stage III-IV.